Prognostic value of serum cholesterol level in Japanese: Patients with coronary artery disease

Japanese Circulation Journal

Volumn 61, Issue 2, 1997, Pages 139-144

  Takahashi, Takuya ^a   Chikamori, Taishiro ^a   Yonezawa, Yoshihiro ^a   Sugimoto, Kazuhiko ^a   Yamada, Mitsutoshi ^a   Takata, Jun ^a   Ozawa, Toshio ^b   Doi, Yoshinori ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Coronary artery disease; Hypercholesterolemia; Prognosis

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICULOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PROGNOSIS; RISK FACTOR; SURVIVAL;

AGED; CHOLESTEROL; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 0030931274     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.61.139     Document Type: Article

References (20)

1. Takai H, Nakai T: Target for the treatment of hyperlipidemia (in Japanese). Medical Practice 1990; 7: 447-452
2. Hosoda S, Kimata S, Tamura K, Nakamura M, Toshima H, Shibata J et al: Follow-up of 2,733 Japanese patients with myocardial infarction. Jpn Circ 1995; 59: 121 -129
3. AHA Committee Report: A reporting system on patients for coronary artery disease. Circulation 1975; 51(Suppl): 5-40
4. Chikamori T, Doi YL, Yamada M, Takata J, Yonezawa Y, Ozawa T: Prognostic value of dipyridamole thallium scintigraphy in patients with coronary artery disease treated medically. Jpn Circ J 1993; 57: 851-861
5. Criqui MH: Cholesterol, primary and secondary prevention, and all-cause mortality. Ann Intern Med 1991; 115: 973-976
6. Levine GN, Keaney JF Jr, Vita JA: Cholesterol reduction in cardiovascular disease. N Engl J Med 1995; 332: 512-521
7. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD: Cholesterol reduction yields clinical benefit: a new look at old data. Circulation 1995; 91: 2274-2282
8. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
9. Yamamoto A: From hyperlipidemia to arteriosclerosis (in Japanese). Medical Practice 1990; 7: 350-361
10. Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 1971; 74: 1-12
11. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet 1986; 2: 933-939
12. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM et al: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990; 322: 1700-1707
13. Rose G, Shipley M: Plasma cholesterol concentration and death from coronary disease: Ten year results of the Whitehall Study, BMJ 1986; 293: 306-307
14. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY et al: Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993; 328: 313-318
15. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69
16. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT et al: The primary prevention of myocardial infarction. N Engl J Med 1992; 326: 1406-1416
17. Chikamori T, Doi Y, Yonezawa Y, Kuzume O, Furuno T, Ozawa T et al: Clinical significance of prominent negative T waves induced by exercise test (in Japanese). J Cardiol 1989; 19: 741-748
18. Chikamori T, Doi YL, Yonezawa Y, Yamada M, Seo H, Ozawa T: Noninvasive identification of significant narrowing of the left main coronary artery by dipyridamole thallium scintigraphy. Am J Cardiol 1991; 68: 472-477
19. MAAS investigators: Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994; 344: 633 -638
20. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233-3240